Longeveron LLC
Biotechnology
Healthcare
LGVN
14.95 M shares
NASDAQ US
traded
05 Aug 2025
listed
no
open
1.53
52 week high
4.55
high
1.59
52 week low
0.00
previous Close
1.71
P/E ratio
market cap
19.81 M
div yield
0
net incoming
-5.01 M
-22.79 %
net profit margin
-1315.22 %
-638.00 %
operating incoming
-5.18 M
-21.02 %
net change in cash
-4.91 M
-38.32 %
cash on hand
14.33 M
-25.50 %
cost of revenue
106 K
45.21 %
top